Lea Andrée

Lea Andrée

Auto-generated profile, based on publicly available information

Lea Andrée

Department of Dentistry—Regenerative Biomaterials, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Philips van Leydenlaan 25, 6525 EX Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2024 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
LALea Andrée
Lea Andrée
LJLucas S. Joziasse
Lucas S. Joziasse
MAMerel J. W. Adjobo-Hermans
Merel J. W. Adjobo-Hermans
FYFang Yang
Fang Yang
RWRong Wang
Rong Wang
Sander LeeuwenburghSander Leeuwenburgh
Sander Leeuwenburgh
Hydroxyapatite nanoparticles (nHA) have gained attention as potential intracellular drug delivery vehicles due to their high binding affinity for various biomolecules and pH-dependent solubility. Yet, the dependence of nHA cytocompatibility on their physicochemical properties remains unclear since numerous studies have revealed starkly contrasting results. These discrepancies may be attributed to differences in size, shape, crystallinity, and aggregation state of nHA, which complicates fundamental understanding of the factors driving nHA cytotoxicity. Here, we hypothesize that nHA cytotoxicity is primarily driven by intracellular calcium levels following the internalization of nHA nanoparticles. By investigating the cytotoxicity of spherical nHA with different crystallinity and dispersity, we find that both lower crystallinity and increased agglomeration of nHA raise cytotoxicity, with nanoparticle agglomeration being the more dominant factor. We show that the internalization of nHA enhances intracellular calcium levels and increases the production of reactive oxygen species (ROS). However, only subtle changes in intracellular calcium are observed, and their physiological relevance remains to be confirmed. In conclusion, we show that nHA agglomeration enhances ROS production and the associated cytotoxicity. These findings provide important guidelines for the future design of nHA-containing formulations for biomedical applications, implying that nHA crystallinity and especially agglomeration should be carefully controlled to optimize biocompatibility and therapeutic efficacy.

29 September 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
LALea Andrée
Lea Andrée
RERik Egberink
Rik Egberink
JDJosephine Dodemont
Josephine Dodemont
NBNegar Hassani Besheli
Negar Hassani Besheli
FYFang Yang
Fang Yang
Sander LeeuwenburghSander Leeuwenburgh
Sander Leeuwenburgh
Messenger RNA (mRNA) is increasingly gaining interest as a modality in vaccination and protein replacement therapy. In regenerative medicine, the mRNA-mediated expression of growth factors has shown promising results. In contrast to protein delivery, successful mRNA delivery requires a vector to induce cellular uptake and subsequent endosomal escape to reach its end destination, the ribosome. Current non-viral vectors such as lipid- or polymer-based nanoparticles have been successfully used to express mRNA-encoded proteins. However, to advance the use of mRNA in regenerative medicine, it is required to assess the compatibility of mRNA with biomaterials that are typically applied in this field. Herein, we investigated the complexation, cellular uptake and maintenance of the integrity of mRNA complexed with gelatin nanoparticles (GNPs). To this end, GNPs with positive, neutral or negative surface charge were synthesized to assess their ability to bind and transport mRNA into cells. Positively charged GNPs exhibited the highest binding affinity and transported substantial amounts of mRNA into pre-osteoblastic cells, as assessed by confocal microscopy using fluorescently labeled mRNA. Furthermore, the GNP-bound mRNA remained stable. However, no expression of mRNA-encoded protein was detected, which is likely related to insufficient endosomal escape and/or mRNA release from the GNPs. Our results indicate that gelatin-based nanomaterials interact with mRNA in a charge-dependent manner and also mediate cellular uptake. These results create the basis for the incorporation of further functionality to yield endosomal release.

1 March 2021 in Materials Today Bio
Verified
Journal Article
Open access
LAL. Andrée
L. Andrée
FYFang Yang
Fang Yang
RBRoland Brock
Roland Brock
Sander LeeuwenburghSander Leeuwenburgh
Sander Leeuwenburgh
Ribonucleic acids (small interfering RNA, microRNA, and messenger RNA) have been emerging as a promising new class of therapeutics for bone regeneration. So far, however, research has mostly focused on stability and complexation of these oligonucleotides for systemic delivery. By comparison, delivery of RNA nanocomplexes from biomaterial carriers can facilitate a spatiotemporally controlled local delivery of osteogenic oligonucleotides. This review provides an overview of the state-of-the-art in the design of biomaterials which allow for temporal and spatial control over RNA delivery. We correlate this concept of spatiotemporally controlled RNA delivery to the most relevant events that govern bone regeneration to evaluate to which extent tuning of release kinetics is required. In addition, inspired by the physiological principles of bone regeneration, potential new RNA targets are presented. Finally, considerations for clinical translation and upscaled production are summarized to stimulate the design of clinically relevant RNA-releasing biomaterials.

17 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VPValentina Palacio-Castañeda
Valentina Palacio-Castañeda
RERik Egberink
Rik Egberink
ASArbaaz Sait
Arbaaz Sait
LALea Andrée
Lea Andrée
BSBenedetta Maria Sala
Benedetta Maria Sala
Wouter VerdurmenWouter Verdurmen
Wouter Verdurmen
To investigate the delivery of next-generation macromolecular drugs, such as engineered proteins and mRNA-containing nanoparticles, there is an increasing push towards the use of physiologically relevant disease models that incorporate human cells and do not face ethical dilemmas associated with animal use. Here, we illustrate the versatility and ease of use of a microfluidic platform for studying drug delivery using high-resolution microscopy in 3D. Using this microfluidic platform, we successfully demonstrate the specific targeting of carbonic anhydrase IX (CAIX) on cells overexpressing the protein in a tumor-mimicking chip system using affibodies, with CAIX-negative cells and non-binding affibodies as controls. Furthermore, we demonstrate this system’s feasibility for testing mRNA-containing biomaterials designed to regenerate bone defects. To this end, peptide- and lipid-based mRNA formulations were successfully mixed with colloidal gelatin in microfluidic devices, while translational activity was studied by the expression of a green fluorescent protein. This microfluidic platform enables the testing of mRNA delivery from colloidal biomaterials of relatively high densities, which represents a first important step towards a bone-on-a-chip platform. Collectively, by illustrating the ease of adaptation of our microfluidic platform towards use in distinct applications, we show that our microfluidic chip represents a powerful and flexible way to investigate drug delivery in 3D disease-mimicking culture systems that recapitulate key parameters associated with in vivo drug application.

16 September 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
LALea Andrée
Lea Andrée
RERik Egberink
Rik Egberink
RHRenée Heesakkers
Renée Heesakkers
CSCeri-Anne E. Suurmond
Ceri-Anne E. Suurmond
LJLucas S. Joziasse
Lucas S. Joziasse
Sander LeeuwenburghSander Leeuwenburgh
Sander Leeuwenburgh
Local delivery of messenger ribonucleic acid (mRNA) is increasingly being advocated as a promising new strategy to enhance the performance of biomaterials. While extensive research has been dedicated to the complexation of these oligonucleotides into nanoparticles to facilitate systemic delivery, research on developing suitable biomaterial carriers for the local delivery of mRNA is still scarce. So far, mRNA-nanoparticles (mRNA-NPs) are mainly loaded into traditional polymeric hydrogels. Here, we show that calcium phosphate nanoparticles can be used for both reinforcement of nanoparticle-based hydrogels and the complexation of mRNA. mRNA was incorporated into lipid-coated calcium phosphate nanoparticles (LCPs) formulated with a fusogenic ionizable lipid in the outer layer of the lipid coat. Nanocomposites of gelatin and hydroxyapatite nanoparticles were prepared at various ratios. Higher hydroxyapatite nanoparticle content increased the viscoelastic properties of the nanocomposite but did not affect its self-healing ability. Combination of these nanocomposites with peptide, lipid, and the LCP mRNA formulations achieved local mRNA release as demonstrated by protein expression in cells in contact with the biomaterials. The LCP-based formulation was superior to the other formulations by showing less sensitivity to hydroxyapatite and the highest cytocompatibility.

13 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CSCeri-Anne E. Suurmond
Ceri-Anne E. Suurmond
KSKe Song
Ke Song
LALea Andrée
Lea Andrée
RWRong Wang
Rong Wang
MDMani Diba
Mani Diba
JBJeroen Van Den Beucken
Jeroen Van Den Beucken
Breast and prostate cancer patients are at high risk of developing bone metastasis. Current treatments are insufficient as evidenced by low 5-year survival rates. To address this challenge bifunctional biomaterials offer the opportunity to both kill cancer cells and regenerate bone after tumor resection. To date these novel biomaterials have been investigated in separate in vitro model systems which target either their anti-cancer efficacy or bone-forming capacity. Herein, we synthesize bifunctional hydroxyapatite nanoparticles functionalized with cisplatin (nHAcis) or without (nHA). Using our recently developed 3D bone metastatic spheroid (BMS) co-culture model for bone metastasis we observed that (unfunctionalized) nHA supplementation does not affect cancer cell proliferation or overall metabolic activity, despite lysosomal uptake of nHA. Remarkably, nHAcis does selectively hamper cancer cell growth in these BMS, demonstrating higher efficacy than cisplatin treatment alone without hampering sustained mineral deposition following osteogenic stimulation with culture media. Overall, we conclude that simultaneous evaluation of both anti-cancer and osteostimulative capacities of novel nanosized bifunctional biomaterials within a single 3D co-culture model evidently goes beyond conventional assessment of these biological functionalities in separate models. Evaluating bifunctional biomaterials in appropriate model systems could accelerate their potential clinical use.